Related Links: Anti-aging treatments, Botox injections, Juvederm injections, Kenallog injections, PRP Therapy, Hair loss treatment, Mesotherapy
The intranasal GHK-Cu treatment was found to delay cognitive impairment, reduce amyloid plaques, and lower inflammation levels in the frontal cortex and hippocampus .37 Randomized controlled trials in human patients are needed to confirm the benefit of GHK-Cu for cognitive decline and Alzheimers disease as well as to evaluate safe and effective human dosing (the human dose equivalent of 15mg/kg in mice would be ~1.2mg/kg, though data on this or any other dosing nasally in humans is not currently available), but preliminary animal trials are promising
Caballero MR, Lukawska J, Lee TH, Dugu P
A B12 deficiency can be difficult to diagnose and is commonly confused with a folate deficiency
References to biological effects are limited to research context only and must not be interpreted as claims of therapeutic, diagnostic, or clinical benefit
Chromosome 16 stayed stable